aripiprazole has been researched along with tetradecanoylphorbol acetate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Han, YH; Hashioka, S; Hirata, E; Horikawa, H; Inoguchi, T; Kanba, S; Kasai, M; Kato, TA; Maeda, Y; Mizoguchi, Y; Monji, A; Seki, Y; Sonoda, N; Utsumi, H; Yasukawa, K | 1 |
1 other study(ies) available for aripiprazole and tetradecanoylphorbol acetate
Article | Year |
---|---|
Aripiprazole inhibits superoxide generation from phorbol-myristate-acetate (PMA)-stimulated microglia in vitro: implication for antioxidative psychotropic actions via microglia.
Topics: Analysis of Variance; Animals; Animals, Newborn; Antipsychotic Agents; Aripiprazole; Brain; Calcium; Cells, Cultured; Drug Interactions; Electron Spin Resonance Spectroscopy; Microglia; NADPH Oxidases; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Superoxides; Tetradecanoylphorbol Acetate | 2011 |